ADVATE/ ADYNOVI Hemophilia A Outcome Database
ADVATE/ ADYNOVI Hemophilia A Outcome Database
The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice
Inclusion Criteria:
Exclusion Criteria:
Murdoch, Western Australia 6050, Australia
Wuhan, Hubei, China
Beijing, 100045, China
Nanjing, China
Rennes, 35033, France
Moscow, 125167, Russia
Saint Petersburg, 191186, Russia
Basingstoke, Hampshire RG24 9NA, United Kingdom
Cambridge, CB2 0QQ, United Kingdom
Canterbury, CT1 3NG, United Kingdom